우리는 비타민 K 길항제로 전환하여 악화되었고, NOAC로 치료한 폐암 및 폐 혈전색전증 환자를 설명한다.
New oral anticoagulants (NOACs) are another treatment option in prevent thromboembolism, but effectiveness for patients with cancer is not clear.